Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 198,156 | 89,476 | 263,269 | 224,979 | 154,465 |
| Depreciation Amortization | 41,696 | 20,804 | 83,140 | 61,620 | 40,893 |
| Income taxes - deferred | 8,638 | 3,005 | -7,918 | -438 | 2,691 |
| Accounts receivable | -32,872 | -21,800 | -24,918 | -18,724 | -32,400 |
| Accounts payable and accrued liabilities | 3 | -1,939 | 1,391 | -3,540 | 1,422 |
| Other Working Capital | -108,727 | -85,438 | 8,380 | -53,685 | -69,356 |
| Other Operating Activity | 46,834 | 30,790 | 49,932 | 41,938 | 43,751 |
| Operating Cash Flow | $153,728 | $34,898 | $373,276 | $252,150 | $141,466 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 284,038 | 284,038 | -47,405 | -44,982 | -19,619 |
| PPE Investments | -51,377 | -23,726 | -74,384 | -54,370 | -38,566 |
| Net Acquisitions | N/A | N/A | -14,579 | -14,529 | -14,529 |
| Purchase Sale Intangibles | N/A | N/A | -2,320 | -320 | N/A |
| Other Investing Activity | 0 | 0 | -2,320 | -320 | 0 |
| Investing Cash Flow | $232,661 | $260,312 | $-138,688 | $-114,201 | $-72,714 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -218,000 | -247,500 | 44,000 | 75,250 | 93,000 |
| Common Stock Issued | 21,905 | 14,551 | 38,622 | 31,314 | 23,170 |
| Common Stock Repurchased | -198,604 | -92,042 | -290,638 | -236,522 | -178,257 |
| Other Financing Activity | -1,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-395,699 | $-324,991 | $-208,016 | $-129,958 | $-62,087 |
| Exchange Rate Effect | -3,806 | 1,335 | 6,202 | 6,127 | 4,409 |
| Beginning Cash Position | 187,675 | 187,675 | 154,901 | 154,901 | 154,901 |
| End Cash Position | 174,559 | 159,229 | 187,675 | 169,019 | 165,975 |
| Net Cash Flow | $-13,116 | $-28,446 | $32,774 | $14,118 | $11,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | 153,728 | 34,898 | 373,276 | 252,150 | 141,466 |
| Capital Expenditure | -51,377 | -23,726 | -74,384 | -54,370 | -38,566 |
| Free Cash Flow | 102,351 | 11,172 | 298,892 | 197,780 | 102,900 |